• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2007 - 2023年以色列产OXA - 48型碳青霉烯酶大肠杆菌出现与传播的基于人群的研究

Population-Based Study of Emergence and Spread of Escherichia coli Producing OXA-48-Like Carbapenemases, Israel, 2007-2023.

作者信息

Temkin Elizabeth, Bechor Moshe, Lurie-Weinberger Mor N, Keren-Paz Alona, Chen Dafna, Lugassy Carmela, Solter Ester, Schwaber Mitchell J, Carmeli Yehuda

出版信息

Emerg Infect Dis. 2025 Jan;31(1):66-74. doi: 10.3201/eid3101.240722.

DOI:10.3201/eid3101.240722
PMID:39714269
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11682801/
Abstract

Escherichia coli producing OXA-48-like carbapenemases (OXA-EC) is considered a high-risk pathogen spread primarily in the community in low- and middle-income countries and nosocomially in high-income countries. We investigated the emergence and spread of OXA-EC in Israel, a high-income country with strong carbapenemase-directed infection control in healthcare institutions, by conducting a population-based study using data and isolates from the national surveillance system. A total of 3,510 incident cases of OXA-EC occurred during 2007-2023. During 2016-2023, annual cases rose from 41 to 1,524 and nonnosocomial cases rose from 39% to 57%. Sixty-three sequenced isolates belonged to 20 sequence types (STs) and had 3 bla alleles (bla, bla, and bla); 71% were chromosomally encoded, and 29% were plasmid-encoded. Nosocomially and non-nosocomially acquired isolates belonged to the same STs and alleles. Most outbreaks involved multiple STs and could only partially be explained by plasmid dissemination. Measures for confronting OXA-EC might need reconsideration.

摘要

产OXA-48样碳青霉烯酶的大肠杆菌(OXA-EC)被认为是一种高风险病原体,主要在低收入和中等收入国家的社区传播,在高收入国家则在医院内传播。我们通过利用国家监测系统的数据和分离株进行一项基于人群的研究,调查了OXA-EC在以色列的出现和传播情况。以色列是一个高收入国家,医疗机构对碳青霉烯酶感染控制力度较大。2007年至2023年期间共发生3510例OXA-EC感染病例。2016年至2023年期间,年度病例数从41例增至1524例,非医院感染病例比例从39%升至57%。63株测序分离株属于20种序列类型(STs),有3种bla等位基因(bla、bla和bla);71%由染色体编码,29%由质粒编码。医院感染和非医院感染分离株属于相同的STs和等位基因。大多数暴发涉及多种STs,仅部分可通过质粒传播来解释。应对OXA-EC的措施可能需要重新考虑。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df06/11682801/c1bbb9c4c3d4/24-0722-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df06/11682801/08286f77e1da/24-0722-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df06/11682801/c18434acfa19/24-0722-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df06/11682801/c1bbb9c4c3d4/24-0722-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df06/11682801/08286f77e1da/24-0722-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df06/11682801/c18434acfa19/24-0722-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df06/11682801/c1bbb9c4c3d4/24-0722-F3.jpg

相似文献

1
Population-Based Study of Emergence and Spread of Escherichia coli Producing OXA-48-Like Carbapenemases, Israel, 2007-2023.2007 - 2023年以色列产OXA - 48型碳青霉烯酶大肠杆菌出现与传播的基于人群的研究
Emerg Infect Dis. 2025 Jan;31(1):66-74. doi: 10.3201/eid3101.240722.
2
Emergence of carbapenem resistant Escherichia coli isolates producing bla and bla-like carried on IncA/C and IncL/M plasmids at two Iranian university hospitals.两伊朗大学医院产碳青霉烯酶的大肠埃希菌分离株的出现,这些菌株携带 bla 和 bla 样基因,位于 IncA/C 和 IncL/M 质粒上。
Infect Genet Evol. 2017 Nov;55:318-323. doi: 10.1016/j.meegid.2017.10.003. Epub 2017 Oct 4.
3
Cross-border emergence of clonal lineages of ST38 Escherichia coli producing the OXA-48-like carbapenemase OXA-244 in Germany and Switzerland.德国和瑞士产 OXA-48 样碳青霉烯酶 OXA-244 的 ST38 型大肠埃希菌克隆系的跨境出现。
Int J Antimicrob Agents. 2020 Dec;56(6):106157. doi: 10.1016/j.ijantimicag.2020.106157. Epub 2020 Sep 9.
4
Multicentre investigation of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in German hospitals.德国医院中产碳青霉烯酶大肠杆菌和肺炎克雷伯菌的多中心调查。
Int J Med Microbiol. 2016 Sep;306(6):415-20. doi: 10.1016/j.ijmm.2016.05.009. Epub 2016 May 13.
5
Surveillance of OXA-244-producing and epidemiologic investigation of cases, Denmark, January 2016 to August 2019.2016 年 1 月至 2019 年 8 月丹麦产 OXA-244 的监测和病例的流行病学调查。
Euro Surveill. 2020 May;25(18). doi: 10.2807/1560-7917.ES.2020.25.18.1900742.
6
Diversity of Carbapenemase-Producing Escherichia coli Isolates in France in 2012-2013.2012-2013 年法国产碳青霉烯酶大肠埃希菌分离株的多样性。
Antimicrob Agents Chemother. 2018 Jul 27;62(8). doi: 10.1128/AAC.00266-18. Print 2018 Aug.
7
Emergence and polyclonal dissemination of NDM-5/OXA-181 carbapenemase-producing Escherichia coli in the French Indian Ocean territories.印度洋法国海外领地中产生NDM-5/OXA-181碳青霉烯酶的大肠杆菌的出现及多克隆传播
Ann Clin Microbiol Antimicrob. 2025 Jan 29;24(1):8. doi: 10.1186/s12941-025-00778-8.
8
A Long-Term Study of the Diversity of OXA-48-Like Carbapenemase-Producing Bacterial Strains in Infected Patients and Carriers.对感染患者和携带者中产生OXA-48样碳青霉烯酶细菌菌株多样性的长期研究。
Microb Drug Resist. 2018 Mar;24(2):181-189. doi: 10.1089/mdr.2017.0060. Epub 2017 Jul 14.
9
Early emergence of OXA-181-producing Escherichia coli ST410 in China.中国产 OXA-181 的大肠杆菌 ST410 的早期出现。
J Glob Antimicrob Resist. 2018 Dec;15:215-218. doi: 10.1016/j.jgar.2018.06.017. Epub 2018 Jul 3.
10
Dissemination of an international high-risk clone of Escherichia coli ST410 co-producing NDM-5 and OXA-181 carbapenemases in Seoul, Republic of Korea.韩国首尔市出现同时产 NDM-5 和 OXA-181 碳青霉烯酶的肠杆菌科 ST410 国际高危克隆的传播。
Int J Antimicrob Agents. 2021 Dec;58(6):106448. doi: 10.1016/j.ijantimicag.2021.106448. Epub 2021 Oct 11.

引用本文的文献

1
A Novel Metallo-β-Lactamase AMM-1 From Alteromonas mangrovi Reveals a Cryptic Environmental Reservoir of Carbapenem Resistance.来自红树林交替单胞菌的新型金属β-内酰胺酶AMM-1揭示了碳青霉烯耐药性的潜在环境储存库。
Microb Biotechnol. 2025 Jul;18(7):e70191. doi: 10.1111/1751-7915.70191.
2
Community Outbreak of OXA-48-Producing Escherichia coli Linked to Food Premises, New Zealand, 2018-2022.2018 - 2022年新西兰与食品经营场所相关的产OXA - 48型大肠杆菌社区暴发
Emerg Infect Dis. 2025 Jul;31(7):1300-1308. doi: 10.3201/eid3107.250289.

本文引用的文献

1
Use of Fourier-transform infrared spectroscopy for real-time outbreak investigation of OXA-48-producing Escherichia coli.利用傅里叶变换红外光谱实时调查产 OXA-48 型大肠埃希菌的爆发情况。
J Antimicrob Chemother. 2024 Feb 1;79(2):349-353. doi: 10.1093/jac/dkad387.
2
Evaluation of Fourier transform-infrared spectroscopy (FT-IR) as a control measure for nosocomial outbreak investigations.评价傅里叶变换红外光谱(FT-IR)作为医院感染暴发调查的控制措施。
J Clin Microbiol. 2023 Oct 24;61(10):e0034723. doi: 10.1128/jcm.00347-23. Epub 2023 Oct 3.
3
Characteristics of community-acquired carbapenem-resistant Enterobacterales.
社区获得性碳青霉烯类耐药肠杆菌科的特征。
J Antimicrob Chemother. 2022 Sep 30;77(10):2763-2771. doi: 10.1093/jac/dkac239.
4
Comparison of fast Fourier transform infrared spectroscopy biotyping with whole genome sequencing-based genotyping in common nosocomial pathogens.常见医院病原体的快速傅里叶变换红外光谱生物分型与全基因组测序基因分型比较。
Anal Bioanal Chem. 2022 Oct;414(24):7179-7189. doi: 10.1007/s00216-022-04270-6. Epub 2022 Aug 13.
5
Carbapenem-Resistant enterobacterales in individuals with and without health care risk factors -Emerging infections program, United States, 2012-2015.耐碳青霉烯肠杆菌科细菌在有和无医疗保健风险因素个体中的分布情况-美国,2012-2015 年。新兴传染病项目。
Am J Infect Control. 2023 Jan;51(1):70-77. doi: 10.1016/j.ajic.2022.04.003. Epub 2022 Jul 28.
6
OXA-48-Like β-Lactamases: Global Epidemiology, Treatment Options, and Development Pipeline.OXA-48 类β-内酰胺酶:全球流行病学、治疗选择和研发管道。
Antimicrob Agents Chemother. 2022 Aug 16;66(8):e0021622. doi: 10.1128/aac.00216-22. Epub 2022 Jul 20.
7
Whole genome sequencing reveals hidden transmission of carbapenemase-producing Enterobacterales.全基因组测序揭示了产碳青霉烯酶肠杆菌科的隐匿性传播。
Nat Commun. 2022 Jun 1;13(1):3052. doi: 10.1038/s41467-022-30637-5.
8
Overview of Changes to the Clinical and Laboratory Standards Institute M100, 31st Edition.临床和实验室标准协会 M100,31 版更改概述。
J Clin Microbiol. 2021 Nov 18;59(12):e0021321. doi: 10.1128/JCM.00213-21. Epub 2021 Sep 22.
9
Emergence and Polyclonal Dissemination of OXA-244-Producing Escherichia coli, France.产 OXA-244 型大肠埃希菌的出现和多克隆传播,法国。
Emerg Infect Dis. 2021 Apr;27(4):1206-1210. doi: 10.3201/eid2704.204459.
10
Multidrug-Resistant Bacteria in the Community: An Update.社区中的耐多药细菌:最新进展。
Infect Dis Clin North Am. 2020 Dec;34(4):709-722. doi: 10.1016/j.idc.2020.08.002. Epub 2020 Sep 30.